跳至主要内容
临床试验/TCTR20140303003
TCTR20140303003已完成3 期

Efficacy and mechanism of curcumin in prevention and treatment of diabetes, liver cirrhosis from nonalcoholic fatty liver disease (NAFLD), depression, and osteoporosis in the patients with type 2 diabetes

Thailand Research Fund0 个研究点目标入组 296 人开始时间: 2014年3月3日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
296

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
25 Years 至 65 Years(—)
性别
All

入选标准

  • type 2 diabetes patients

排除标准

  • - type 1 diabetes
  • - renal failure with serum creatinine > 2.0 md/dL
  • - secondary cause of chronic hepatitis
  • - Liver failure with AST and ALT over than 2.5 times of upper limit
  • - heavy alcoholic drinking
  • - receiving anti-hyperglycemic drugs ( TZD, DDP-IV inhibitor, insulin, GLP-1 agonist) and antihyperlipid drugs (fenofibrate, gemfibrozile and ezetrol)
  • - receiving other herbal
  • - secondary cause of hyperglycemia
  • - history of inflammatory and infection diseases
  • - pregnancy women
  • - history of gall stone or cholecystectomy

研究者

发起方
Thailand Research Fund

相似试验